| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8604168 | The American Journal of Medicine | 2017 | 27 Pages |
Abstract
Cancer was not associated with a higher risk of stroke. The superior efficacy and safety of apixaban versus warfarin were consistent in patients with and without cancer. Our positive findings regarding apixaban use in patients with atrial fibrillation and cancer are exploratory and promising, but warrant further evaluation.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Chiara MD, MHS, Allison MS, Christopher B. MD, Laine PhD, Michel G. MD, David A. MD, Elaine M. MD, MPH, Michael MD, Lars MD, PhD, Bernard J. MB, ChB, DPhil, Pamela S. MD, John H. MD, MHS, Renato D. MD, MHS, PhD,